Caladrius Biosciences Inc. (CLBS) slipped -7.19% or -0.42 to $5.42. It is close to 17329 shares traded, which is 14.28% compare to the average total volume 121381. The market cap of CLBS is $51.78 million. The year to date change is 57.84%. The 52 week price range is from $2.63 to $6.35. Price of CLBS have changed -1.02% during last week. It have changed 24.26% over last month, 57.84% over last 3 months, 60.00% over last 6 months and 22.69% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLBS is 4.76. It is -12.18% below current price. The 200-day Moving Averages for CLBS is 4.04. It is -25.46% below current price. The 52-week High is 6.35. It is 17.16% from the current price. The 52-week Low is 2.63. It is -51.48% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLBS is 0.31 on 2018-03-15. Short % to float is 2.82%. There are some statistics of CLBS. It is has market cap $51.78 million. The share outstanding is 9.55 million. The average volume is 121381. The revenue is 7.92M. It has 130.82M cash and 7.09M in debt. The gross profit is -119598. The percent of top 15 Institution holding is 5.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLBS is 81.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLBS is 36.94%.